BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26712115)

  • 1. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
    Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
    Deekonda S; Wugalter L; Kulkarni V; Rankin D; Largent-Milnes TM; Davis P; Bassirirad NM; Lai J; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem; 2015 Sep; 23(18):6185-94. PubMed ID: 26299827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
    Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies.
    Watanabe Y; Kitazawa S; Nemoto T; Hirayama S; Iwai T; Fujii H; Nagase H
    Bioorg Med Chem; 2013 Jun; 21(11):3032-50. PubMed ID: 23623711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters.
    Mehr-Un-Nisa ; Munawar MA; Rankin D; Hruby VJ; Porreca F; Lee YS
    Bioorg Med Chem; 2021 Dec; 51():116509. PubMed ID: 34798381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.
    Deekonda S; Wugalter L; Rankin D; Largent-Milnes TM; Davis P; Wang Y; Bassirirad NM; Lai J; Kulkarni V; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4683-8. PubMed ID: 26323872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.
    Lee YS; Petrov R; Park CK; Ma SW; Davis P; Lai J; Porreca F; Vardanyan R; Hruby VJ
    J Med Chem; 2007 Nov; 50(22):5528-32. PubMed ID: 17927164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues.
    Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A
    J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent μ and δ opioid agonists with high lipophilicity.
    Lee YS; Kulkarani V; Cowell SM; Ma SW; Davis P; Hanlon KE; Vanderah TW; Lai J; Porreca F; Vardanyan R; Hruby VJ
    J Med Chem; 2011 Jan; 54(1):382-6. PubMed ID: 21128594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.
    Lee YS; Nyberg J; Moye S; Agnes RS; Davis P; Ma SW; Lai J; Porreca F; Vardanyan R; Hruby VJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2161-5. PubMed ID: 17329100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
    Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
    Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles.
    Grundt P; Jales AR; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2003 Apr; 46(8):1563-6. PubMed ID: 12672258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists.
    Jiang L; Beattie DT; Jacobsen JR; Kintz S; Obedencio GP; Saito D; Stergiades I; Vickery RG; Long DD
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2926-2930. PubMed ID: 28499731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ
    García M; Llorente V; Garriga L; Christmann U; Rodríguez-Escrich S; Virgili M; Fernández B; Bordas M; Ayet E; Burgueño J; Pujol M; Dordal A; Portillo-Salido E; Gris G; Vela JM; Almansa C
    J Med Chem; 2021 Jul; 64(14):10139-10154. PubMed ID: 34236190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
    Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
    Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.
    Váradi A; Palmer TC; Haselton N; Afonin D; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; Marrone GF; Borics A; Majumdar S
    ACS Chem Neurosci; 2015 Sep; 6(9):1570-7. PubMed ID: 26148793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.